The Ambivalent Function of YAP in Apoptosis and Cancer
AbstractYes-associated protein, a core regulator of the Hippo-YAP signaling pathway, plays a vital role in inhibiting apoptosis. Thus, several studies and reviews suggest that yes-associated protein is a good target for treating cancer. Unfortunately, more and more evidence demonstrates that this protein is also an essential contributor of p73-mediated apoptosis. This questions the concept that yes-associated protein is always a good target for developing novel anti-cancer drugs. Thus, the aim of this review was to evaluate the clinical relevance of yes-associated protein for cancer pathophysiology. This review also summarized the molecules, processes and drugs, which regulate Hippo-YAP signaling and discusses their effect on apoptosis. In addition, issues are defined, which should be addressed in the future in order to provide a solid basis for targeting the Hippo-YAP signaling pathway in clinical trials. View Full-Text
Share & Cite This Article
Zhang, X.; Abdelrahman, A.; Vollmar, B.; Zechner, D. The Ambivalent Function of YAP in Apoptosis and Cancer. Int. J. Mol. Sci. 2018, 19, 3770.
Zhang X, Abdelrahman A, Vollmar B, Zechner D. The Ambivalent Function of YAP in Apoptosis and Cancer. International Journal of Molecular Sciences. 2018; 19(12):3770.Chicago/Turabian Style
Zhang, Xianbin; Abdelrahman, Ahmed; Vollmar, Brigitte; Zechner, Dietmar. 2018. "The Ambivalent Function of YAP in Apoptosis and Cancer." Int. J. Mol. Sci. 19, no. 12: 3770.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.